These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 15814656

  • 1. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2735-46. PubMed ID: 15814656
    [Abstract] [Full Text] [Related]

  • 2. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB.
    J Exp Ther Oncol; 2005 Apr 01; 5(1):69-78. PubMed ID: 16416603
    [Abstract] [Full Text] [Related]

  • 3. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
    Sah JF, Balasubramanian S, Eckert RL, Rorke EA.
    J Biol Chem; 2004 Mar 26; 279(13):12755-62. PubMed ID: 14701854
    [Abstract] [Full Text] [Related]

  • 4. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
    Zhang X, Min KW, Wimalasena J, Baek SJ.
    J Cancer Res Clin Oncol; 2012 Dec 26; 138(12):2051-60. PubMed ID: 22814742
    [Abstract] [Full Text] [Related]

  • 5. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
    Masuda M, Suzui M, Lim JT, Weinstein IB.
    Clin Cancer Res; 2003 Aug 15; 9(9):3486-91. PubMed ID: 12960141
    [Abstract] [Full Text] [Related]

  • 6. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
    Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, Weinstein IB.
    Cancer Res; 2007 Jul 01; 67(13):6493-501. PubMed ID: 17616711
    [Abstract] [Full Text] [Related]

  • 7. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB.
    J Exp Ther Oncol; 2002 Jul 01; 2(6):350-9. PubMed ID: 12440226
    [Abstract] [Full Text] [Related]

  • 8. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong AN.
    Carcinogenesis; 2003 Aug 01; 24(8):1369-78. PubMed ID: 12819184
    [Abstract] [Full Text] [Related]

  • 9. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB.
    Biochem Biophys Res Commun; 2005 Sep 02; 334(3):947-53. PubMed ID: 16053920
    [Abstract] [Full Text] [Related]

  • 10. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
    Masuda M, Suzui M, Weinstein IB.
    Clin Cancer Res; 2001 Dec 02; 7(12):4220-9. PubMed ID: 11751523
    [Abstract] [Full Text] [Related]

  • 11. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N, Agarwal C, Agarwal R.
    Nutr Cancer; 2001 Dec 02; 39(2):292-9. PubMed ID: 11759294
    [Abstract] [Full Text] [Related]

  • 12. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H.
    Oncogene; 2003 Jul 31; 22(31):4851-9. PubMed ID: 12894226
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH, Han DW, Hyon SH, Park JC.
    Apoptosis; 2011 Jan 31; 16(1):75-85. PubMed ID: 20963498
    [Abstract] [Full Text] [Related]

  • 14. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS.
    Oncol Rep; 2012 Nov 27; 28(5):1799-807. PubMed ID: 22923287
    [Abstract] [Full Text] [Related]

  • 19. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL, Cardelli JA.
    Oncogene; 2006 Mar 23; 25(13):1922-30. PubMed ID: 16449979
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.